KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ELYM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Eliem Therapeutics, Inc. stock price on Friday moving 25.09% between high and low
(Updated on Apr 26, 2024)

Buy or Hold candidate since Apr 12, 2024 Loss -7.66% PDF

The Eliem Therapeutics, Inc. stock price gained 17.40% on the last trading day (Friday, 26th Apr 2024), rising from $3.39 to $3.98. During the last trading day the stock fluctuated 25.09% from a day low at $3.33 to a day high of $4.16. The price has fallen in 7 of the last 10 days and is down by -7.66% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 191 thousand more shares were traded than the day before. In total, 580 thousand shares were bought and sold for approximately $2.31 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 35.94% during the next 3 months and, with a 90% probability hold a price between $3.96 and $6.71 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ELYM Signals & Forecast

The Eliem Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $3.81 and $3.21. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 15, 2024, and so far it has fallen -16.21%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Eliem Therapeutics, Inc. stock

Eliem Therapeutics, Inc. finds support from accumulated volume at $3.85 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.83 between high and low, or 25.09%. For the last week, the stock has had daily average volatility of 13.26%.

Our recommended stop-loss: $3.75 (-5.72%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 9 days ago.)

Trading Expectations (ELYM) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Eliem Therapeutics, Inc. to open at $3.82, and during the day (based on 14 day Average True Range), to move between $3.56 and $4.40, which gives a possible trading interval of +/-$0.416 (+/-10.46%) up or down from last closing price. If Eliem Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 20.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.85 (3.27%) than the resistance at $4.31 (8.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Eliem Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Eliem Therapeutics, Inc. stock to perform well in the short-term.

Current score: 3.561 Buy Candidate Unchanged

Predicted Opening Price for Eliem Therapeutics, Inc. of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$3.82 ( 3.98%) $3.98

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ELYM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.66 16.97 %
R2 4.34 8.97 %
R1 4.14 4.02 %
Current price: 3.98
Support S1 3.50 -11.99 %
S2 3.31 -16.94 %
S3 2.99 -24.94 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.75 19.35 %
R2 4.58 15.08 %
R1 4.31 8.29 %
Current price 3.98
Support S1 3.85 -3.27%
S2 3.66 -8.04%
S3 3.39 -14.82%

FAQ

What is the symbol for Eliem Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Eliem Therapeutics, Inc. is ELYM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Eliem Therapeutics, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Eliem Therapeutics, Inc. stock to perform well in the short-term.

How to buy Eliem Therapeutics, Inc. Stock?
Eliem Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Eliem Therapeutics, Inc. Stock.

What's the current price of Eliem Therapeutics, Inc. Stock?
As of the end of day on the Apr 26, 2024, the price of an Eliem Therapeutics, Inc. (ELYM) share was $3.98.

What is the 52-week high and low for Eliem Therapeutics, Inc. Stock?
The 52-week high for Eliem Therapeutics, Inc. Stock is $5.18 and the 52-week low is $2.34.

What is the market capitalization of Eliem Therapeutics, Inc. Stock?
As of the Apr 26, 2024, the market capitalization of Eliem Therapeutics, Inc. is 110.323M.

When is the next earnings date for Eliem Therapeutics, Inc.?
The upcoming earnings date for Eliem Therapeutics, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Eliem Therapeutics, Inc.

Eliem Therapeutics. Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase IIa clinical trial; and ETX-155 for the treatment of major depressive disorder, perimenopausal depression... ELYM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT